谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Correction To: Gr-MDSC-linked Asset As a Potential Immune Biomarker in Pretreated NSCLC Receiving Nivolumab As Second-Line Therapy

A. Passaro, P. Mancuso, S. Gandini,G. Spitaleri, V. Labanca,E. Guerini-Rocco, M. Barberis,C. Catania,E. Del Signore,F. de Marinis, F. Bertolini

Clinical and Translational Oncology（2020）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要